Milestone Pharmaceuticals Inc. - Common Shares — Bilancio Trimestrale (NASDAQ:MIST) | MetaTrader

Apri il grafico completo Full chart

Notizie

Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call Transcript

Milestone Reports Q1 Results, Highlights Initial CARDAMYST Sales - Milestone Pharmaceuticals (NASDAQ:MIST

Milestone Pharmaceuticals (MIST) Reports Q1 Loss, Lags Revenue Estimates

Gli EPS di Milestone Pharmaceuticals hanno mancato le aspettative per 0,43$, il fatturato appena sotto le previsioni

Milestone Pharmaceuticals: il titolo crolla del 16% per i ricavi deludenti

Milestone Pharmaceuticals pianifica studio di registro PSVT nel mondo reale

Raymond James avvia la copertura di Milestone Pharmaceuticals con Strong Buy

Milestone Pharmaceuticals Inc. (MIST) Q4 2025 Earnings Call Transcript

Transcript della relazione sugli utili: Milestone Pharmaceuticals raggiunge le previsioni EPS, titolo in calo

Milestone Pharmaceuticals Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Milestone Pharmaceuticals (NASDAQ:MIST)

Milestone Stock: Downgrading To Sell As CARDAMYST Faces A Tough Reality (NASDAQ:MIST)

Milestone Pharmaceuticals appoints David Sandoval as general counsel